{"about":{"non_affiliation":"Code with Papers and Syntology are not affiliated with, endorsed by, or sponsored by Papers with Code, Meta, or the pwc-archive mirror.","site":"https://codewithpapers.app","licence":"CC BY-SA 4.0","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","attribution":"https://codewithpapers.app/attribution","modified":"archive material modified by Syntology; see the attribution page","syntology":{"site":"https://syntology.ai","developers":"https://syntology.ai/developers","mcp":{"server":"https://syntology.ai/mcp","transport":"streamable-http","server_card":"https://syntology.ai/.well-known/mcp/server-card.json","auth":{"type":"trial token, no account","trial_token":"https://syntology.ai/api/oauth/trial/token","method":"POST","docs":"https://syntology.ai/developers"}},"have":"https://syntology.ai/api/graph/have?x=<method, arXiv id or title> (free, answers coverage only)","paper_base":"https://syntology.ai/paper/","atlas_base":"https://app.syntology.ai/?focus="},"machine_readable":[{"url":"https://codewithpapers.app/llms.txt","what":"the machine catalog: every machine-readable file, counted"},{"url":"https://codewithpapers.app/index/manifest.json","what":"paper-to-code index by arXiv id, with Syntology's counts"},{"url":"https://codewithpapers.app/search/manifest.json","what":"site search index (titles, authors) and its files"},{"url":"https://codewithpapers.app/download","what":"bulk files: Syntology's layer, described there"},{"url":"https://codewithpapers.app/build_manifest.json","what":"the build record: inputs, counts, exclusions, probes"}]},"url":"/paper/the-coming-of-age-of-nucleic-acid-vaccines","title":"The Coming of Age of Nucleic Acid Vaccines during COVID-19","arxiv_id":"2210.07247","date":"2022-10-14","proceeding":null,"authors":["Halie M. Rando","Ronan Lordan","Likhitha Kolla","Elizabeth Sell","Alexandra J. Lee","Nils Wellhausen","Amruta Naik","Jeremy P. Kamil","COVID-19 Review Consortium","Anthony Gitter","Casey S. Greene"],"abstract":"In the 21st century, several emergent viruses have posed a global threat. Each pathogen has emphasized the value of rapid and scalable vaccine development programs. The ongoing SARS-CoV-2 pandemic has made the importance of such efforts especially clear. New biotechnological advances in vaccinology allow for recent advances that provide only the nucleic acid building blocks of an antigen, eliminating many safety concerns. During the COVID-19 pandemic, these DNA and RNA vaccines have facilitated the development and deployment of vaccines at an unprecedented pace. This success was attributable at least in part to broader shifts in scientific research relative to prior epidemics; the genome of SARS-CoV-2 was available as early as January 2020, facilitating global efforts in the development of DNA and RNA vaccines within two weeks of the international community becoming aware of the new viral threat. Additionally, these technologies that were previously only theoretical are not only safe but also highly efficacious. Although historically a slow process, the rapid development of vaccines during the COVID-19 crisis reveals a major shift in vaccine technologies. Here, we provide historical context for the emergence of these paradigm-shifting vaccines. We describe several DNA and RNA vaccines and in terms of their efficacy, safety, and approval status. We also discuss patterns in worldwide distribution. The advances made since early 2020 provide an exceptional illustration of how rapidly vaccine development technology has advanced in the last two decades in particular and suggest a new era in vaccines against emerging pathogens.","url_abs":"https://arxiv.org/abs/2210.07247v2","url_pdf":"https://arxiv.org/pdf/2210.07247v2.pdf","source":{"archive":"pwc-archive (Hugging Face), CC BY-SA 4.0","snapshot":"2025-07-28","licence_url":"https://creativecommons.org/licenses/by-sa/4.0/legalcode","row_kind":"abstracts"},"code_links":[{"paper_slug":"the-coming-of-age-of-nucleic-acid-vaccines","repo_url":"https://github.com/greenelab/covid19-review","is_official":1,"mentioned_in_paper":1,"mentioned_in_github":1,"framework":"none","reach":null}],"tasks":[],"methods":[{"method_slug":"aware","method_name":"AWARE"}],"datasets_introduced":[],"methods_introduced":[],"results":[],"syntology":{"syntology_url":null,"atlas_url":null,"mcp":null,"developers":"https://syntology.ai/developers","held":null,"reason":"arxiv_id_not_in_atlas","checked_against":{"atlas_ids":549449,"atlas_ids_sha256":"afd72399dafd9906e9062927f70655952385a3d75488558e1f0484e950ab09b7","read_at":"2026-10-05T01:46:21Z"},"by_repo":[{"repo":"greenelab/covid19-review","kind":"official","samples":0,"ran":0,"instrument":0,"unverified":0}],"by_repo_is":"one row per repository in the archive's code links, Syntology's graph links or the samples; samples 0 means no sample is linked to this paper, a statement about Syntology's coverage, not about the repository: with harvested_for_other_papers present, Syntology harvested the repository for that many other papers, and without it, Syntology harvested nothing from it; placed_by_identical_code counts samples whose link records no repository, placed here because identical code was harvested from this repository for another paper; ran counts executions on a synthesized input and instrument counts failures of Syntology's instrument, not of the code"},"code_links_note":null,"arxiv_metadata":null,"syntology_extracted_results":null,"record_sha256":"e9eff1355cce1b66e0e09067835e4647b0469253e9b77c31484d245f382fcf64","record_changed_at":"2026-09-28","record_changed_at_basis":"first_hashed"}